Reaching Others University at Buffalo - The State University of New York
Skip to Content

News and Events

10/20/14

Federal approval of new drugs to treat the hepatitis C virus (HCV) represents “a dramatic, positive development for patients,” says University at Buffalo liver disease expert Andrew H. Talal, MD.

10/20/14

The contract for the second — and by far the largest — phase of construction has been awarded for the University at Buffalo’s new School of Medicine and Biomedical Sciences.

Frederick Sachs, PhD
10/20/14
A drug developed by University at Buffalo scientists from a small protein found in spider venom is moving forward as a promising treatment for Duchenne muscular dystrophy, a fatal genetic disease affecting boys.
Ariel Engelman
10/20/14

First-year medical student Ariel Engelman has been honored with the Robert Wood Johnson Foundation Fellowship for her demonstrated commitment to diversity and inclusion.

10/20/14

Federal approval of new drugs to treat the hepatitis C virus (HCV) represents “a dramatic, positive development for patients,” says University at Buffalo liver disease expert Andrew H. Talal, MD.

10/20/14

The contract for the second — and by far the largest — phase of construction has been awarded for the University at Buffalo’s new School of Medicine and Biomedical Sciences.

"); pageTracker._trackPageview();